|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07K 1/00 | (2006.01) |
| C07K 1/14 | (2006.01) | ||
| C07K 14/00 | (2006.03) | ||
| C08G 69/10 | (2006.01) |
| (11) | Number of the document | 2177528 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10150124.5 |
| Date of filing the European patent application | 2005-09-09 | |
| (97) | Date of publication of the European application | 2010-04-21 |
| (45) | Date of publication and mention of the grant of the patent | 2011-12-07 |
| (46) | Date of publication of the claims translation | 2012-04-25 |
| (30) | Number | Date | Country code |
| 608843 P | 2004-09-09 | US |
| (72) |
Dolitzky, Ben-Zion, IL
|
| (73) |
Teva Pharmaceutical Industries Ltd.,
5 Basel Street P.O. Box 3190, 49131 Petah Tiqva,
IL
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Trifluoracetilglatiramero acetato mišinių gavimo būdas, naudojant išgrynintą hidrobromido rūgštį |
| Process for the preparation of mixtures of trifluoroacetyl glatiramer acetate using purified hydrobromic acid |
| Payment date | Validity (years) | Amount | |
| 2015-09-01 | 11 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2015-11-09 |